Latest Market News

RocketBoots Limited has successfully converted its AI-powered retail banking trial into a contract rollout with a major Australian bank, marking a significant step in its commercial expansion.

LGI Limited reported robust FY25 results with a 14% rise in EBITDA and secured six new contracts, positioning the company for a 25-30% EBITDA increase in FY26. Key project completions and expansions underpin this momentum.

EML Payments has affirmed its FY26 underlying EBITDA guidance of A$58-63 million following a solid Q1 trading update, underpinned by a growing new program pipeline and operational efficiencies.

Ausgold Limited has raised A$80 million through a fully underwritten placement to fast-track the Katanning Gold Project, aiming for a final investment decision by mid-2026. The capital injection strengthens the company’s balance sheet and supports key development milestones.

LGI Limited reported robust FY25 results, expanding electricity capacity by 44% and increasing EBITDA by 14%, driven by new landfill gas contracts and battery storage projects. The company is well positioned to capitalize on Australia’s renewable energy transition and evolving carbon credit market.

White Energy Company Limited has launched a $3.5 million entitlement offer to fund exploration across its copper projects, with drilling already underway at the Specimen Hill site in Queensland. The company is leveraging AI and advanced geophysics to target high-grade copper zones, aiming for a near-term discovery.

Environmental Clean Technologies is set to convert a $1.13 million convertible note into equity, significantly reducing debt and freeing resources to advance its PFAS remediation technology.

White Energy Company Limited has announced a partially underwritten entitlement offer to raise approximately $3.5 million at a 10% discount, aimed at funding key mineral exploration projects across Australia.

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in FSGS kidney disease has passed its seventh Independent Data Monitoring Committee review with no safety concerns, reinforcing the drug’s promising safety profile.

Horizon Oil Limited reported robust FY25 results, highlighted by a strategic acquisition of Thailand upstream assets and a 10-year permit extension at Maari, nearly doubling production and securing a strong outlook through 2030.

Prospect Resources has identified 11 strong electromagnetic conductors at its Mumbezhi Copper Project in Zambia, highlighting promising new exploration targets including the 2.5km Chipimpa cluster. With Phase 2 drilling complete and assay results pending, the company aims to update its Mineral Resource estimate in early 2026.

Prescient Therapeutics has achieved a key regulatory milestone with the European Medicines Agency granting Orphan Drug Designation for its PTX-100 therapy targeting Cutaneous T-cell Lymphomas, enhancing its commercial and clinical prospects in Europe.